Indian pharma company Biocon launched a Rs5.28 billion to Rs5.5 billion ($82.2 million to $85.7 million) initial public offering in its clinical research arm Syngene International on Monday.
Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.
Note: This free trial is a one-time offer.
Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.
